Evoqua Water Technologies는 물과 폐수 처리 제품의 전문 기업으로 미국의 Food & Drug Administration(FDA)사의 아칸소(Arkansas)주 제퍼슨 강(Jefferson)에 위치한 아칸소 지역 위원회와 계약을 갱신하게 됐다. 이는 최신기술이며, 상하수도에서 초순수로 이온을 제거하는 방식이다.

FDA의 성공적인 활동으로 공중 위생을 보호하며, 실험실을 통해 신속하고 정확하게 샘플을 분석할 수 있는 능력을 갖추고 있다. 물의 초순수 방식은 시정 조치를 정확하게 분석하는 핵심이다. Evoqua는 FDA에 역삼투 방식, 제어시스템 및 탈이온화 방식을 이용해 순수한 물을 제공할 방침이며, 이번에 계약을 5년 갱신했다.

Evoqua Water Technologies, a specialist in water and wastewater treatment products, has been awarded a renewal contract to supply the U.S. Food & Drug Administration's (FDA) Arkansas Regional Laboratory in Jefferson, Ark., with its state-of-the-art ultrapure laboratory deionized water system.

The success of FDA activities to protect public health often depends on the ability of the Agency's laboratories to quickly and accurately analyze samples. Ultrapure water is key to accurate analysis and suggesting corrective action.

The contract awarded to Evoqua renews a five-year agreement with the FDA where Evoqua has supplied reverse osmosis, control systems and deionization to meet its pure water needs. The contract also calls for Evoqua to provide ongoing service of the equipment and systems.

The Arkansas Regional Lab, a 146,400-square foot facility, was built as part of FDA's plan to reorganize its 18 field laboratories within its Office of Regulatory Affairs. The Arkansas Regional Lab consists of a Director's Office, General Chemistry Branch, Pesticide Chemistry Branch, Veterinary Sciences Branch, Microbiology Branch, Animal Drug Research Center and a Total Diet and Pesticide Research Center.

 

[출처 = Water World / 2015년 7월 16일]